Company / Operating Cash Flow per Share
NewAmsterdam Pharma Co N.V. Operating Cash Flow per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$4.08
FY2025
5-year range
-$4.37 / $0.56
FY2021-FY2025
Trend
+6.8%
vs FY2024
Sector context
#190 of 212
Health Care
What the data says
Among 212 Health Care companies, NewAmsterdam Pharma Co N.V. is in the bottom 10% for operating cash flow per share. Operating Cash Flow per Share returned to growth in FY2025 after 2 years of decline, reaching $-4.08.
Based on SEC 10-K filings.
-4.08 in FY2025.
Declined from $-3.89 to $-4.08 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 212This company -$4.08 Sector average -$14.72
▼
+72.3% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 6.8% year-over-year.
- Ranks #190 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2022.
- Lowest operating cash flow per share in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.08 | +6.8% |
| FY2024 | -$4.37 | -12.3% |
| FY2023 | -$3.89 | -792.6% |
| FY2022 | $0.56 | +120.9% |
| FY2021 | -$2.69 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026